搜索





搜索





市场行情
/
股票
/
zntl
/

Zentalis Pharmaceuticals Inc

ZNTL

添加自选

4.740USD

-0.180-3.66%

收盘 07-31 16:00（美东）报价延迟15分钟

337.42M总市值

亏损市盈率 TTM

Zentalis Pharmaceuticals Inc

4.740

-0.180-3.66%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

ZNTL 利润表

您可以在这里找到Zentalis Pharmaceuticals Inc的年度或季度收入报告，以深入了解Zentalis Pharmaceuticals Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q1

营业总收入

----

-100.00%0.00

--0.00

-100.00%0.00

--26.86M

--0.00

--40.56M

----

营业收入

----

-100.00%0.00

--0.00

--26.86M

--0.00

----

营业费用

3.22%37.85M

-48.76%37.39M

-34.41%33.73M

-44.65%36.06M

-43.86%36.67M

7.44%72.98M

-17.99%51.43M

11.65%65.15M

8.96%65.33M

31.24%67.92M

15.73%62.72M

-8.06%58.35M

3.58%59.95M

7.39%51.75M

0.23%54.19M

15.11%63.46M

14.96%57.88M

19.75%48.19M

55.52%54.07M

101.39%55.13M

207.01%50.35M

--40.24M

--34.77M

--27.38M

88.02%16.40M

--8.72M

研发费用

10.04%28.72M

-10.57%29.49M

-37.68%22.95M

-42.94%27.61M

-47.37%26.09M

-36.05%32.97M

-21.26%36.82M

13.36%48.39M

2.06%49.59M

26.94%51.56M

10.87%46.77M

-2.60%42.68M

5.36%48.58M

5.66%40.62M

-6.68%42.18M

-2.11%43.83M

20.10%46.11M

30.21%38.44M

83.21%45.20M

156.53%44.77M

189.59%38.39M

--29.52M

--24.67M

--17.45M

87.02%13.26M

--7.09M

折旧摊销及损耗

-42.37%151.00K

-52.13%157.00K

-54.02%160.00K

-51.07%160.00K

-19.14%262.00K

-5.75%328.00K

0.00%348.00K

-4.94%327.00K

-10.00%324.00K

-3.06%348.00K

-7.20%348.00K

-1.15%344.00K

4.65%360.00K

71.77%359.00K

173.72%375.00K

192.44%348.00K

335.44%344.00K

186.30%209.00K

168.63%137.00K

213.16%119.00K

107.89%79.00K

--73.00K

--51.00K

--38.00K

80.95%38.00K

--21.00K

营业利润

-3.22%-37.85M

18.91%-37.39M

34.41%-33.73M

44.65%-36.06M

-48.09%-36.67M

32.11%-46.11M

17.99%-51.43M

-11.65%-65.15M

58.69%-24.77M

-31.24%-67.92M

-15.73%-62.72M

8.06%-58.35M

-3.58%-59.95M

-7.39%-51.75M

-0.23%-54.19M

-15.11%-63.46M

-14.96%-57.88M

-19.75%-48.19M

-55.52%-54.07M

-101.39%-55.13M

-207.01%-50.35M

---40.24M

---34.77M

---27.38M

-88.02%-16.40M

---8.72M

净非营业利息收入（费用）

利息收入

----

-12.80%143.00K

----

121.62%164.00K

--74.00K

出售证券收益

198.76%2.62M

20.58%2.62M

-37.38%7.04M

140.17%9.18M

-107.60%-2.66M

-68.28%2.17M

56.01%11.25M

-613.66%-22.86M

750.52%34.95M

111.88%6.85M

278.43%7.21M

949.76%4.45M

864.55%4.11M

3572.73%3.23M

1824.24%1.91M

268.70%424.00K

--426.00K

-72.06%88.00K

-17.50%99.00K

36.90%115.00K

----

--315.00K

--120.00K

--84.00K

----

特殊收入（费用）

100.00%0.00

--0.00

---8.95M

---3.74M

--0.00

100.00%0.00

----

--0.00

---45.57M

---5.00M

--0.00

-100.00%0.00

----

--0.00

--42.78M

----

其他非经营性收入（费用）

----

---44.00K

----

100.00%0.00

---12.00K

税前利润

27.02%-35.23M

27.06%-34.77M

33.58%-26.69M

69.47%-26.87M

-574.11%-48.28M

21.94%-47.68M

27.61%-40.19M

11.52%-88.01M

116.74%10.18M

-25.87%-61.07M

-6.16%-55.51M

-57.79%-99.47M

-5.90%-60.84M

-0.87%-48.52M

-367.32%-52.29M

-14.58%-63.04M

-14.34%-57.45M

-20.47%-48.10M

67.71%-11.19M

-101.59%-55.02M

-209.50%-50.25M

---39.93M

---34.65M

---27.29M

-87.47%-16.23M

---8.66M

所得税

--120.00K

315.61%442.00K

100.00%0.00

-100.00%0.00

-51.85%-205.00K

-187.10%-27.00K

143.97%266.00K

32.41%143.00K

62.50%-135.00K

119.50%31.00K

-3658.82%-605.00K

227.27%108.00K

-326.42%-360.00K

77.19%-159.00K

-62.22%17.00K

-83.16%33.00K

-62.68%159.00K

-3972.22%-697.00K

--45.00K

--196.00K

--426.00K

--18.00K

----

--3.00K

除税后的权益收益

----

--0.00

100.00%0.00

-156.73%-13.70M

-31.92%-2.31M

-272.58%-6.82M

---2.37M

---5.34M

---1.75M

---1.83M

----

除税后利润

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-580.87%-48.28M

22.10%-47.47M

27.70%-40.16M

10.71%-88.28M

116.47%10.04M

-26.53%-60.94M

-6.54%-55.54M

-56.79%-98.86M

-6.03%-60.95M

0.21%-48.16M

-396.85%-52.13M

-14.51%-63.05M

-13.96%-57.49M

-19.60%-48.26M

69.73%-10.49M

-101.75%-55.06M

-210.71%-50.44M

---40.36M

---34.66M

---27.29M

-87.41%-16.23M

---8.66M

持续经营利润

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-580.87%-48.28M

22.10%-47.47M

27.70%-40.16M

21.58%-88.28M

115.87%10.04M

-10.83%-60.94M

-1.91%-55.54M

-64.59%-112.56M

-6.79%-63.26M

-9.76%-54.98M

-419.44%-54.50M

-24.21%-68.39M

-17.43%-59.24M

-24.13%-50.09M

69.73%-10.49M

-101.75%-55.06M

-210.71%-50.44M

---40.36M

---34.66M

---27.29M

-87.41%-16.23M

---8.66M

归属少数股东的净利润

----

--0.00

100.00%0.00

34.88%-28.00K

-69.23%-22.00K

87.88%-12.00K

-5.71%-37.00K

73.13%-43.00K

63.89%-13.00K

98.43%-99.00K

92.83%-35.00K

70.53%-160.00K

32.08%-36.00K

-5628.18%-6.30M

-12.18%-488.00K

-398.17%-543.00K

---53.00K

---110.00K

---435.00K

65.94%-109.00K

---320.00K

归属于母公司的净利润

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-579.53%-48.28M

22.07%-47.47M

27.68%-40.16M

21.55%-88.28M

115.93%10.07M

-10.82%-60.92M

-2.07%-55.53M

-64.62%-112.53M

-7.01%-63.22M

-9.81%-54.97M

-1198.04%-54.40M

-25.26%-68.36M

-18.39%-59.08M

-24.21%-50.06M

87.87%-4.19M

-103.20%-54.57M

-209.44%-49.90M

---40.30M

---34.55M

---26.86M

-93.29%-16.13M

---8.34M

归属于普通股东的净利润

26.78%-35.35M

25.82%-35.22M

33.54%-26.69M

69.56%-26.87M

-579.53%-48.28M

22.07%-47.47M

27.68%-40.16M

21.55%-88.28M

115.93%10.07M

-10.82%-60.92M

-2.07%-55.53M

-64.62%-112.53M

-7.01%-63.22M

-9.81%-54.97M

-1198.04%-54.40M

-25.26%-68.36M

-18.39%-59.08M

-24.21%-50.06M

87.87%-4.19M

-103.20%-54.57M

-209.44%-49.90M

---40.30M

---34.55M

---26.86M

-93.29%-16.13M

---8.34M

基本每股收益

25.30%-0.50

26.22%-0.49

34.48%-0.37

69.96%-0.37

-574.30%-0.67

22.55%-0.67

28.19%-0.56

32.87%-1.24

113.32%0.14

9.05%-0.86

17.88%-0.79

-38.42%-1.85

18.32%-1.07

15.00%-0.95

-919.32%-0.96

0.18%-1.34

-5.61%-1.31

-10.47%-1.11

89.68%-0.09

-96.21%-1.34

-164.53%-1.24

---1.01

---0.91

---0.68

-93.28%-0.47

---0.24

稀释每股收益

25.30%-0.50

26.22%-0.49

34.48%-0.37

69.96%-0.37

-576.28%-0.67

22.55%-0.67

28.19%-0.56

32.87%-1.24

113.26%0.14

9.05%-0.86

17.88%-0.79

-38.42%-1.85

18.32%-1.07

15.00%-0.95

-919.32%-0.96

0.18%-1.34

-5.61%-1.31

-10.47%-1.11

89.68%-0.09

-96.21%-1.34

-164.53%-1.24

---1.01

---0.91

---0.68

-93.28%-0.47

---0.24

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Zentalis Pharmaceuticals Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 ZNTL 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Zentalis Pharmaceuticals Inc 全年的净利润是多少？



Zentalis Pharmaceuticals Inc 2025 财年净利润为 -137.06M。

Zentalis Pharmaceuticals Inc 上一季度的净利润是多少？



Zentalis Pharmaceuticals Inc 最近一个季度的净利润为 -35.35M。

Zentalis Pharmaceuticals Inc 年度营业利润是多少？



Zentalis Pharmaceuticals Inc 2025 财年的营业利润为 -145.01M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。